Official Italian Agency for AIFA Procedure
Any Italian Pharmaceutical Company supporting or participating in a congress abroad, is subjected to an authorization by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124). The request of authorization must be submitted within 60 days before the starting date of the event. Italian Pharmaceutical Companies are advised to contact the Official Agency appointed by the Organising secretariat:
AIM Group International – AIM Education S.r.l. – Milan has been appointed as the Official Italian Agency for AIFA submission, as follows.
The First EFIC Topical Symposium – Acute and Chronic Joint Pain’ is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net
The ‘The First EFIC Topical Symposium – Acute and Chronic Joint Pain’ is designated for a maximum of (or ‘for up to’) 13 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.
Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.